Innovative Eyewear Inc
For the period ended Dec 31, 2024. Filed Mar 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 24, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
On December 13, 2024, Harrison Gross, our Chief Executive Officer, adopted a Rule 10b5-1 trading plan, which is effective through August 31, 2025. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Gross’ income tax withholding obligations associated with the issuance of 19,200 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of 2,880 shares of common stock. As such, the estimated aggregate number of shares to be sold pursuant to this arrangement is 8,718.
On December 13, 2024, Konrad Dabrowski, our Co-Chief Financial Officer, adopted a Rule 10b5-1 trading plan, which is effective through August 31, 2025. The terms of this arrangement provide for the sale of stock to cover Mr. Dabrowski’s income tax withholding obligations associated with the issuance of 16,800 shares of common stock in connection with the vesting of restricted stock units. As such, the estimated aggregate number of shares to be sold pursuant to this arrangement is 4,982.
On December 13, 2024, Oswald Gayle, our Co-Chief Financial Officer, adopted a Rule 10b5-1 trading plan, which is effective through December 2, 2025. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Gayle’s income tax withholding obligations associated with the issuance of 10,800 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 100% of the net vested shares of common stock at certain specified limit prices. As such, the estimated minimum aggregate number of shares to be sold pursuant to this arrangement is 3,204, and the maximum aggregate number of shares that may be sold pursuant to this arrangement is 10,800.
On December 13, 2024, David Eric Cohen, our Chief Technology Officer, adopted a Rule 10b5-1 trading plan, which is effective through December 2, 2025. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Cohen’s income tax withholding obligations associated with the issuance of 14,400 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 3,038 of the net vested shares of common stock at certain specified limit prices. As such, the estimated minimum aggregate number of shares to be sold pursuant to this arrangement is 4,270, and the estimated maximum aggregate number of shares that may be sold pursuant to this arrangement is 7,308.
On December 13, 2024, Joaquin Abondano, our Chief Operating Officer, adopted a Rule 10b5-1 trading plan, which is effective through December 18, 2025. The terms of this arrangement provide for (i) the sale of stock to cover Mr. Abondano’s income tax withholding obligations associated with the issuance of 9,600 shares of common stock in connection with the vesting of restricted stock units, plus (ii) the sale of up to 40% of the net vested shares of common stock at certain specified limit prices. As such, the estimated minimum aggregate number of shares to be sold pursuant to this arrangement is 2,848, and the estimated maximum aggregate number of shares that may be sold pursuant to this arrangement is 5,548.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.